VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
COSM
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
COSMCosmos Health Inc.
$0.24$13M
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksCOSMBalance Sheet

Cosmos Health Inc. (COSM) Balance Sheet

17Y historyFree accessUpdated daily

The company's financial leverage has intensified significantly, with the debt-to-equity ratio rising from 0.34 in 2023Q4 to 1.08 by 2025Q4, reflecting a deteriorating capital structure.

COSM Balance Sheet

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricTTMDec'25Dec'24Dec'23Dec'22Dec'21Dec'20Dec'19Dec'18Dec'17Dec'16Dec'15Dec'14Dec'13Dec'12Jul'11Jul'10Jul'09
Total Current Assets36.89M38.39M25.46M36.61M56.04M39.83M40.77M21.18M18.35M9.51M2.64M547.18K7.21M864.92K015.24K4700
Cash & Short-Term Investments548.93K761.83K336.25K3.85M20.76M297.95K851.19K277.48K3.58M782.85K716.59K198.05K446.6K864.49K015.24K4700
Cash Only514.7K715.67K315.11K3.83M20.75M286.49K628.39K38.54K864.34K782.85K716.59K198.05K446.6K864.49K015.24K4700
Short-Term Investments34.23K46.16K21.15K20.07K14.88K11.47K222.79K238.94K2.72M000000000
Accounts Receivable21.46M22.56M15.88M21.71M22.76M30.14M26.91M9.27M4.94M1.43M793.75K96.54K000000
Days Sales Outstanding107.67126.16106.5148.47165.02195.59177.2785.2648.6517.3542.8966.01------
Inventory5.65M5.78M4.36M4.79M3.45M3.15M3.29M3.47M3.2M3.09M464.22K191.87K000000
Days Inventory Outstanding32.5736.7631.7235.6528.3823.9825.3835.2133.7140.2427.53144.46------
Other Current Assets9.23M9.29M4.89M1.95M9.07M-4.77K1.1M665.49K189.76K772.62K006.73M00000
Total Non-Current Assets25.48M27.09M28.85M29.41M11.67M9.6M3.07M2.7M2.35M1.17M481.92K110.44K21.59K2.13K0000
Property, Plant & Equipment10.95M11.78M10.4M11.62M2.93M2.93M1.76M1.73M1.43M114.57K52.72K50.53K11.99K00000
Fixed Asset Turnover5.84x5.54x5.23x4.60x17.18x19.17x31.53x22.87x26.01x261.97x128.15x10.56x636.96x-----
Goodwill49.7K49.7K49.7K49.7K49.7K49.7K49.7K49.7K49.7K000000000
Intangible Assets9.24M7.52M7.71M7.63M657.22K436.07K180.81K213.98K247.07K41.99K00000000
Long-Term Investments005.77M165.93K0004.38K0000000000
Other Non-Current Assets5.23M7.74M4.92M9.94M8.03M5.33M905.32K698.06K624.48K1.01M429.2K59.92K9.6K2.13K0000
Total Assets62.37M65.48M54.31M66.01M68.04M49.43M43.84M23.88M20.69M10.68M3.12M657.62K7.23M867.05K015.24K4700
Asset Turnover1.07x1.00x1.00x0.81x0.74x1.14x1.26x1.66x1.79x2.81x2.17x0.81x1.06x1.04x----
Asset Growth %38.98%20.56%-17.73%-2.97%37.65%12.74%83.61%15.39%93.85%242.33%374.21%-90.91%734.39%--100%3142.13%--
Total Current Liabilities34.08M38.27M25.76M24.32M21.75M29.93M34.29M28.24M22.27M13.7M4.87M1.91M1.76M920.73K1.4K20K17.95K4.6K
Accounts Payable14.82M14.62M11.16M11.91M10.26M12.13M11.97M8M5.93M2.17M591.69K336.93K159.45K530.18K1.4K02.08K4.6K
Days Payables Outstanding83.6993.0381.2688.6884.3692.3992.3181.162.4628.1835.09253.67821.97347.12----
Short-Term Debt11.89M13.52M9.55M8.23M8.04M13.34M19.7M18.65M15.02M10.18M3.2M474.14K504.12K165K0015.87K0
Deferred Revenue (Current)00000022.34K247.32K1.07M0062.21K06710000
Other Current Liabilities7.37M7.11M3.35M3.47M2.7M1.3M799.73K165.27K111.21K0000186.59K0-20K00
Current Ratio1.08x1.00x0.99x1.51x2.58x1.33x1.19x0.75x0.82x0.69x0.54x0.29x4.10x0.94x-0.76x0.03x-
Quick Ratio0.92x0.85x0.82x1.31x2.42x1.23x1.09x0.63x0.68x0.47x0.45x0.19x4.10x0.94x-0.76x0.03x-
Cash Conversion Cycle56.5569.8856.9695.45109.03127.18110.3439.3719.9129.4235.33-43.2------
Total Non-Current Liabilities8.47M8.78M4.02M5.65M6.63M15.12M13.72M2.1M1.74M000000000
Long-Term Debt6.12M5.85M1.56M3.04M2.86M12.72M11.27M01.55M000000000
Capital Lease Obligations1.72M373.47K501.8K850.13K860.1K844.42K778.71K435.55K0000000000
Deferred Tax Liabilities000000000000000000
Other Non-Current Liabilities1.88M2.56M1.96M1.76M2.91M1.55M1.66M1.66M183.58K000000000
Total Liabilities42.54M47.05M29.78M29.97M28.38M45.05M48.01M30.34M24.01M13.7M4.87M1.91M1.76M920.73K1.4K20K17.95K4.6K
Total Debt18.48M19.97M11.82M12.42M12.03M27.12M32.04M19.29M16.58M10.18M3.2M474.14K504.12K165K0015.87K0
Net Debt17.97M19.25M11.51M8.59M-8.72M26.84M31.41M19.25M15.71M9.4M2.48M276.09K57.51K-699.49K0-15.24K15.4K0
Debt / Equity0.93x1.08x0.48x0.34x0.30x6.19x------0.09x-----
Debt / EBITDA-1.12x-----10.30x138.93x----0.07x0.57x----
Net Debt / EBITDA-1.09x-----10.10x138.65x----0.01x-2.42x----
Interest Coverage-6.00x-6.30x-14.99x-20.40x-2.29x-1.19x1.43x-0.80x-0.33x-2.79x-1.91x-73.00x95.73x118.37x-6.03x-201.68x-3978.23x-
Total Equity19.83M18.42M24.53M36.04M39.66M4.38M-4.16M-6.46M-3.32M-3.03M-1.75M-1.25M5.47M-53.68K-1.4K-4.76K-17.48K-4.6K
Equity Growth %-100.69%-24.9%-31.93%-9.11%805.52%205.25%35.6%-94.75%-9.56%-72.74%-40.47%-122.8%10296%-3726.37%70.54%72.76%-280.02%-
Book Value per Share0.420.611.283.0120.576.67-7.82-12.17-6.23-5.92-3.49-2.4810.88-0.13-0.01-0.05-0.21-0.06
Total Shareholders' Equity19.83M18.42M24.53M36.04M39.66M4.38M-4.16M-6.46M-3.32M-3.03M-1.75M-1.25M5.47M-53.68K-1.4K-4.76K-17.48K-4.6K
Common Stock49.87K41.15K23.69K15.98K10.61K70213.48K13.22K13.88K12.82K125.87K125.63K125.59K125.59K100K24.51K24.22K20K
Retained Earnings-135.97M-133.17M-114.02M-91.64M-66.23M-34.35M-18.75M-19.57M-16.27M-7.21M-1M-401.22K6.29M242K-4.59K0-3.79M0
Treasury Stock-917.16K-917.16K-917.16K-917.16K-816.71K-816.71K-611.85K-411.85K-225.49K-95.88K00000000
Accumulated OCI36.44K331.5K-2.13M-419.84K-1.13M-151.62K854.9K-16.34K32.83K-1.39M-1.05M-1.11M-680.97K11.32K-1.25K-3.96M-3.79M-4.6K
Minority Interest000000000000000000

Key Metrics

Growth RegimeExpanding
ProfitabilityNegative
Balance SheetVulnerable
Cash FlowBurning
Top Statement Risk

Imminent liquidity and dilution

Verified Source

Metrics are mathematically derived from official filings.

SEC 10-K (2026Q1)

Deteriorating Financial Position Over Time

As reported in recent financial filings, COSM's equity base has contracted from $36.0M in 2023Q4 to $18.4M by 2025Q4, reflecting a persistent erosion of shareholder value driven by recurring net losses and an inability to achieve operational scale despite aggressive top-line expansion efforts.

The consistent decline in equity suggests that the company's growth strategy is currently value-destructive, as the capital raised or retained is being consumed by operating deficits rather than asset appreciation. Investors should monitor whether this trajectory forces a pivot toward more conservative capital allocation or if the current trend of balance sheet depletion continues unabated.

Rising Leverage Amidst Operational Losses

Based on the company's reported figures, the debt-to-equity ratio has climbed from 0.34 in 2023Q4 to 1.08 in 2025Q4, indicating that management is increasingly relying on debt financing to bridge the gap between operational cash outflows and the capital requirements of its distribution business.

This shift toward higher leverage is particularly concerning given the company's negative operating margins, as it increases the interest burden on a business that lacks a reliable cash-generative core. The reliance on debt in a high-rate environment may indicate a lack of alternative financing options, potentially limiting future strategic flexibility.

Critical Cash Runway and Solvency

According to the most recent balance sheet data, COSM's cash reserves have plummeted to just $715.7K as of 2025Q4, a level that appears dangerously insufficient to support the company's $65.3M TTM revenue scale and ongoing working capital requirements in the volatile pharmaceutical distribution sector.

The current ratio hovering near 1.00 suggests that the company has virtually no margin for error regarding its short-term obligations. This liquidity profile warrants significant caution, as any delay in accounts receivable collection or a sudden spike in supplier payment demands could trigger a severe solvency event.

Erosion of Shareholder Equity Base

As evidenced by the quarterly balance sheets, retained earnings have deepened to a deficit of $133.2M in 2025Q4, signaling that years of operational losses have systematically depleted the company's equity and necessitated a reliance on external capital to maintain basic business continuity.

The persistent negative retained earnings highlight a fundamental disconnect between the company's revenue growth and its ability to generate internal capital. This trend suggests that shareholders may face continued dilution as the company likely seeks to replenish its equity base to offset the ongoing cash burn.

Hidden Risks in Asset Valuation

Based on the reported figures, the company's reliance on $11.8M in net PPE and the potential volatility of its intangible assets suggest that the balance sheet may be overstating the tangible value available to creditors in the event of a liquidation or operational restructuring.

The concentration of assets in PPE and potentially illiquid inventory creates a risk where the book value of assets may not reflect their actual market value during a distress scenario. Investors should be wary of the quality of these assets, as they appear to be failing to generate the returns necessary to justify their carrying values.

COSM — Frequently Asked Questions

Quick answers to the most common questions about buying COSM stock.

What are the total assets of Cosmos Health Inc. (COSM)?

As of 2025, Cosmos Health Inc. (COSM) had total assets of $65.5M including $38.4M in current assets.

How much debt does Cosmos Health Inc. (COSM) have?

Cosmos Health Inc. (COSM) carries total debt of $20.0M, offset by $0.8M in cash and short-term investments. Comparing total debt to cash helps evaluate the company's debt burden and net leverage.

What is the book value or shareholders' equity of Cosmos Health Inc.?

Cosmos Health Inc. (COSM) has total shareholders' equity (book value) of $18.4M ($0.61 book value per share). Book value represents the net worth of the company belonging to common stock holders.

What is Cosmos Health Inc.'s current ratio and liquidity?

Cosmos Health Inc. (COSM) reported a current ratio of 1.00x. A current ratio above 1.0x indicates that the company has more current assets than current liabilities, suggesting sufficient short-term liquidity.